Terumo (TRUMY)
(Delayed Data from OTC)
$17.16 USD
-0.12 (-0.69%)
Updated Jun 7, 2024 03:59 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TRUMY 17.16 -0.12(-0.69%)
Will TRUMY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for TRUMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TRUMY
Terumo (TRUMY) Moves to Strong Buy: Rationale Behind the Upgrade
Best Momentum Stocks to Buy for March 28th
TRUMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for March 28th
Here's What Could Help Terumo Corp. (TRUMY) Maintain Its Recent Price Strength
What Makes Terumo Corp. (TRUMY) a Good Fit for 'Trend Investing'
Other News for TRUMY
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System
Terumo Corporation (TRUMY) Q4 2024 Earnings Call Transcript
Terumo Corporation reports FY GAAP EPS of ¥71.47
FDA Clears the Individualized Nomogram for Rika Plasma Donation System